Atlas Venture, a Cambridge-based investor, has reportedly closed its ninth fund with $265 million in capital commitments. The fund's final tally eclipsed its original target of $250 million. Atlas focuses on early-stage tech and life sciences companies, with a focus on the Boston scene. The firm closed its eighth fund on $283 million in commitments in 2009.
